For Consumers

FDA Office of Women's Health Update Archive

 The words Women's Health Alert

 

The Office of Women's Health e-Update highlights women's health initiatives, meetings, and regulatory safety information from the U.S. Food and Drug Administration (FDA). The e-Update is disseminated via email to the public.

Current Issue: March 2017

Message from the Director

 
For over 100 years, FDA has supported research, policies, and outreach to protect and promote women’s health. When Congress passed the Pure Food and Drugs Act in 1906, infections were the leading causes of death and infirmity; and many women suffered due to adulterated and misbranded products. Since that time, there have been many scientific advances that have allowed women and their families to live longer and experience a better quality of life. 
 
This is Women’s History Month and it is a time when we can reflect on how far we have come over the years and new directions for the future. I encourage you to explore the timeline of some of FDA’s accomplishments in women’s health. I also invite you to read about the scientists, field inspectors, doctors and other women who have made notable contributions to FDA and paved the way for future generations of women in STEM. Lastly, I ask that you read this eUpdate to find ways that you too can get involved in FDA’s work. Participate in one of the upcoming workshops and public meetings highlighted here. Share the safety messages and other resources to help women make informed choices about their healthcare. Those early women pioneers showed us that our individual and collective actions can make a difference.
 
Marsha Henderson - Assistant Commissioner for Women’s Health
 
****************************************

Women’s Health Highlights

Viberzi (eluxadoline): Drug Safety Communication - Increased Risk of Serious Pancreatitis In Patients Without A Gallbladder
FDA is warning that Viberzi (eluxadoline), a medicine used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder. An FDA review found these patients have an increased risk of developing serious pancreatitis that could result in hospitalization or death. Pancreatitis may be caused by spasm of a certain digestive system muscle in the small intestine. As a result, FDA is working with the Viberzi manufacturer, Allergan, to address these safety concerns.
 
Read the Drug Safety Communication
 
****************************************
Women’s History Month 
Throughout its history, FDA has worked to protect the health of women and their families. From issuing warnings about unsafe products for pregnant women to improving mammography quality, women’s health has remained a priority for FDA. This Women’s History Month, celebrate by learning more about FDA’s historical impact on women’s health and some of the trailblazing women who helped to make that work possible.
 
***************************************
New Blog: FDA’s Commitment to Women’s Heart Health Research
A new blog from OWH Director, Marsha Henderson, highlights the history of FDA research on QT prolongation and demonstrates the ways ongoing collaborations across FDA research programs are helping to advance policies and projects to protect women’s heart health.
 
 
***************************************
March is Save Your Vision Month
FDA has resources to help women make informed choices about contact lenses for themselves and their children. Share these resources to help women and their families keep their eyes safe.
 
***************************************

Extras

Spring Break Resources 
Encourage young women to keep safety in mind while enjoying time away from classes. Share these digital tools with your networks to help keep students safe. 
 
***************************************

Extras

FDA's Food and Cosmetic Information Center Answers Your Questions
FDA’s Food and Cosmetic Information Center (FCIC) answers questions about nutrition and the safety and accurate labeling of food, dietary supplements, and cosmetics. You can contact FCIC by phone and/or e-mail Monday through Friday, from 10 a.m. to 4 p.m. at 1-888-SAFEFOOD (1-888-723-3366) or, submit questions by filling out the online form.disclaimer icon
 
 
****************************************

Meetings

 
Participate in upcoming FDA Public Meetings.
 
March 17, 2017, 7:30 am to 4:00 pm
Hilton Washington, DC North/Gaithersburg, Gaithersburg, MD
 
March 30, 2017, 12:00 pm to 1:00 pm
Webcast
 
April 6, 2017, 1:00 pm to 5:00 pm
FDA White Oak Campus, Silver Spring, MD
 
April 19 - 20, 2017, 8:30 am to 4:30 pm
FDA White Oak Campus, Silver Spring, MD
 
***************************************
Visit the OWH exhibit booth at these upcoming conferences. 
 
Aging in America
March 20-24, 2017, Chicago, IL
 
The Society for Public Health Education (SOPHE)
March 30 - April 1, 2017, Denver, CO
 __________________________________________________________________ 
 

 Past OWH e-Update Issues

Contact FDA

301-796-9440
Fax:301-847-8604
Food and Drug Administration Office of Women's Health

10903 New Hampshire Avenue

WO32-2333

Silver Spring, MD 20993

Page Last Updated: 03/20/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English